Niels Riedemann is the founder of InflaRx. Latest round: IPO. He led the company's Nasdaq IPO in 2017 and has overseen multiple financing rounds.
Prof. Dr. Niels Riedemann is the Co-Founder and CEO of InflaRx, a clinical-stage biopharmaceutical company focused on developing anti-inflammatory therapies targeting the complement system. He led the company's Nasdaq IPO in 2017 and has overseen multiple financing rounds. Under his leadership, InflaRx is developing drug candidates to treat severe immune-mediated diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library